Marienhaus Klinikum Mainz

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Obesity2 trials
• Heart failure1 trial
• Lung cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Amgen2 trials
• neuroloop GmbH1 trial
• Pierre Fabre Medicament1 trial
• ReCor Medical, Inc.1 trial

Running trials

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

• Recruiting

  The "Global Paradise System" Registry

  NCT05027685· ReCor Medical, Inc.· Source

  Contact: Bärbel Kasesberger

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• High blood pressure1 recruiting
• Obesity1 recruiting

Closed trials

• Terminated

  Baroloop Multicenter Trial (Baroloop MCT)

  NCT06518915· neuroloop GmbH· Source

• Completed

  A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

  NCT05546905· Pierre Fabre Medicament· Source